Tapeworm drug nanotherapy sparks hope for non-hormonal endometriosis treatment BioTechniques
Endometriosis relief? New non-hormonal drug targets lesions directly The Indian Express
Endometriosis is a chronic, estrogen-dependent inflammatory disease that, despite its benign histology, displays several cancer-relevant features, including clonal expansion, somatic alteration-associated lesion evolution, tissue invasion, apoptosis resistance, immune evasion, angiogenesis, …
Excessive activation of inflammatory responses and oxidative stress plays a critical role in the pathophysiology of endometriosis (EMs), which is characterized by ectopic lesion growth and chronic pelvic pain. However, …
Endometriosis is a chronic inflammatory disease characterised by pain, infertility and recurrence. Current pharmacological management relies largely on hormonal suppression, which can reduce pain and disease activity but does not …
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery Monash University
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery monash.edu
Endometriosis is a chronic, heterogeneous gynaecological disorder characterised by the presence of endometrial-like tissue outside the uterine cavity and is associated with pain, infertility, and reduced quality of life. Emerging …
Endometriosis is a chronic inflammatory and estrogen-dependent disease in which oxidative stress, immune dysregulation, and lesion-supportive microenvironmental signaling contribute to lesion development. N-acetylcysteine (NAC), a glutathione-replenishing and redox-modulating agent, has …
Researchers Investigate Non-Hormonal Alternatives for Uterine Fibroids and Endometriosis Affecting Up to 80% of Women geneonline.com